BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32596959)

  • 1. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma.
    Huang C; Li J; Zhang X; Xiong T; Ye J; Yu J; Gui Y
    FASEB J; 2020 Aug; 34(8):10623-10639. PubMed ID: 32596959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p.
    Wang ZY; Zhu Z; Wang HF; Qin B; Liu J; Yao XH; Li WC; Chen KS
    J Cell Physiol; 2019 Aug; 234(10):17775-17785. PubMed ID: 30864145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E2F1-miR-520/372/373-SPOP Axis Modulates Progression of Renal Carcinoma.
    Ding M; Lu X; Wang C; Zhao Q; Ge J; Xia Q; Wang J; Zen K; Zhang CY; Zhang C
    Cancer Res; 2018 Dec; 78(24):6771-6784. PubMed ID: 30348808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircSCNN1A inhibits the proliferation, migration and invasion of renal cell carcinoma cells by decreasing CLDN8 expression through miR-590-5p.
    Guo T; Xiong W; Liu C; Zhu L; Xie L
    Genesis; 2024 Jun; 62(3):e23599. PubMed ID: 38764323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circAMOTL1L Suppresses Renal Cell Carcinoma Growth by Modulating the miR-92a-2-5p/KLLN Pathway.
    Gao L; Shao X; Yue Q; Wu W; Yang X; He X; Li L; Hou F; Zhang R
    Oxid Med Cell Longev; 2021; 2021():9970272. PubMed ID: 34646428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.
    Cen J; Liang Y; Huang Y; Pan Y; Shu G; Zheng Z; Liao X; Zhou M; Chen D; Fang Y; Chen W; Luo J; Zhang J
    Mol Cancer; 2021 Jan; 20(1):19. PubMed ID: 33468140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein.
    Tang Y; Li K; Hu B; Cai Z; Li J; Tao H; Cao J
    Cancer Biol Ther; 2022 Dec; 23(1):424-438. PubMed ID: 35816613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma.
    Liu W; Li H; Wang Y; Zhao X; Guo Y; Jin J; Chi R
    Gene; 2017 Aug; 626():275-281. PubMed ID: 28536082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.
    Jin S; Chen L; Wu J; Chen M; Wang H; Hu H; Yu L; Zeng S
    Int J Immunopathol Pharmacol; 2023; 37():3946320231184997. PubMed ID: 37584255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 14. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
    Zhao H; Xie Z; Tang G; Wei S; Chen G
    J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.
    Zhu K; Miao C; Tian Y; Qin Z; Xue J; Xia J; Zhu S; Xu A; Yang J; Wang Z
    J Cell Mol Med; 2020 Sep; 24(17):10013-10026. PubMed ID: 33460239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
    Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
    J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axis.
    Zhai X; Wu Y; Zhang D; Li H; Chong T; Zhao J
    J Bioenerg Biomembr; 2021 Apr; 53(2):191-202. PubMed ID: 33686550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-141 promotes cell proliferation and invasion in non-small cell lung cancer by targeting KLF9.
    Kong YJ; Tan XX; Zhang Y; He QJ; Zhao L; Meng Q
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10370-10378. PubMed ID: 31841191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0005875 sponges miR-502-5p to promote renal cell carcinoma progression through upregulating E26 transformation specific-1.
    Luo S; Deng F; Yao N; Zheng F
    Anticancer Drugs; 2022 Jan; 33(1):e286-e298. PubMed ID: 34407050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF9 inhibits the proliferation, invasion, and migration of renal cell carcinoma through the SDF-1/CXCR4 axis.
    Yu P; Cheng L; Xia WM; Liu DY; Yu JS; Zhou YF; Zheng YJ
    Kaohsiung J Med Sci; 2023 Jun; 39(6):587-595. PubMed ID: 37010151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.